Hugh Salter, Head, AstraZeneca Translational Science Center at Karolinska Institutet




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Hugh Salter, Head, AstraZeneca Translational Science Center at Karolinska Institutet
Released on: November 22, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton, CEO PharmaVentures talks to Hugh Salter, Head, AstraZeneca Translational Science Center at Karolinska Institutet.
  • Summary
  • Transcript
  • Participants
  • Company
In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton, CEO PharmaVentures talks to Hugh Salter, Head, AstraZeneca Translational Science Center at Karolinska Institutet. They discuss how, by establishing a set of collaborative research programmes focusing on discovering and validating biomarkers, AstraZeneca is developing a toolkit that will sharpen their understanding of diseases and be better able to identify patients suitability for the next generation of treatments.
In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton, CEO PharmaVentures talks to Hugh Salter, Head, AstraZeneca Translational Science Center at Karolinska Institutet. They discuss how, by establishing a set of collaborative research programmes focusing on discovering and validating biomarkers, AstraZeneca is developing a toolkit that will sharpen their understanding of diseases and be better able to identify patients suitability for the next generation of treatments.
Hugh Salter
Karolinska Institutet
Karolinska Insitutet